LENZ Therapeutics Market Cap

LENZ Therapeutics has a market cap or net worth of $416.71 million as of May 17, 2024. Its market cap has increased by 132.15% in one year.

Market Cap

416.71M

Enterprise Value

203.47M

1-Year Change

132.15%

Ranking

#3127

Market Cap Chart

Since the IPO on June 25, 2021, LENZ Therapeutics's market cap has decreased from $951.31M to $416.71M, a decrease of -56.20%. That is a compound annual growth rate of -24.80%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	417.50M	-1.09%
May 16, 2024	422.10M	4.35%
May 15, 2024	404.50M	0.77%
May 14, 2024	401.40M	-1.21%
May 13, 2024	406.30M	1.15%
May 10, 2024	401.70M	2.16%
May 9, 2024	393.20M	-4.82%
May 8, 2024	413.10M	202.19%
May 7, 2024	136.70M	1.56%
May 6, 2024	134.60M	-1.68%
May 3, 2024	136.90M	0.29%
May 2, 2024	136.50M	3.80%
May 1, 2024	131.50M	-0.38%
Apr 30, 2024	132.00M	-3.86%
Apr 29, 2024	137.30M	4.97%
Apr 26, 2024	130.80M	1.79%
Apr 25, 2024	128.50M	-2.58%
Apr 24, 2024	131.90M	-0.38%
Apr 23, 2024	132.40M	0.15%
Apr 22, 2024	132.20M	-0.83%
Apr 19, 2024	133.30M	-8.38%
Apr 18, 2024	145.50M	-1.22%
Apr 17, 2024	147.30M	-11.10%
Apr 16, 2024	165.70M	-2.59%
Apr 15, 2024	170.10M	-6.59%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Lexicon Pharmaceuticals	437.07M
Acelyrin	434.23M
Pulse Biosciences	432.41M
PepGen	430.82M
Neurogene	428.54M
Nevro	416.32M
Enhabit	413.38M
Health Catalyst	410.29M

Market Cap Rankings